Free Sleep CEU- Managing Insomnia by Targeting Neurotransmitters

insomniaTargeting Neurotransmitters for the Management of Insomnia– Insomnia can affect many aspects of an individual’s life: impairing concentration and memory, increasing the risk of incident depression or recurrence of a depressive episode, diminishing a patient’s ability to enjoy family and social relationships, and increasing the risks of falls and motor vehicle accidents.
This neuroscienceCME Clinical Navigator  will describe the treatments used in insomnia, so that clinicians understand more about the roles of neurotransmitters and therapeutic agents, including orexin antagonists. It is important for clinicians to be aware of emerging agents in order to tailor treatments to individual needs as new therapeutic options for insomnia become available.
Evaluate how research findings for emerging agents will likely affect routine clinical practice in the care of patients with insomnia.

1.0 Free CEUs for Sleep Technologists

This course also offers Free CME for Physicians

Expires 10/17/15
neuroscience logo


Supported by an independent educational grant from Merck & Co., Inc.
This entry was posted in Sleep Tech and tagged , , , , , , . Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s